(Q43825956)

English

Bovine oocytes treated prior to in vitro maturation with a combination of butyrolactone I and roscovitine at low doses maintain a normal developmental capacity

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Bovine oocytes treated prior to in vitro maturation with a combination of butyrolactone I and roscovitine at low doses maintain a normal developmental capacity (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

author name string

N Ponderato

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

I Lagutina

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

G Crotti

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P Turini

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

C Galli

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

G Lazzari

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Molecular Reproduction and Development

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

579-585

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Growth and development of the mammalian oocyte

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Butyrolactone I reversibly inhibits meiotic maturation of bovine oocytes,Without influencing chromosome condensation activity.

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Bovine blastocyst production in vitro after inhibition of oocyte meiotic resumption for 24 h.

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Bovine oocyte and embryo development following meiotic inhibition with butyrolactone I.

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Chemical inhibitors of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Hormonal and follicular factors affecting maturation of sheep oocytes in vitro and their subsequent developmental capacity

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Interplay between CDC2 kinase and MAP kinase pathway during maturation of mammalian oocytes

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

THE COMPARATIVE BEHAVIOR OF MAMMALIAN EGGS IN VIVO AND IN VITRO : I. THE ACTIVATION OF OVARIAN EGGS

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Role of the cyclic adenosine monophosphate-dependent protein kinase in the control of meiotic resumption in bovine oocytes cultured with thecal cell monolayers.

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Developmental capacity of bovine oocytes following inhibition of meiotic resumption by cycloheximide or 6-dimethylaminopurine

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Controlling meiotic resumption in bovine oocytes: a review.

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Successful culture in vitro of sheep and cattle ova

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Use of ethylene glycol as a cryoprotectant for bovine embryos allowing direct transfer of frozen-thawed embryos to recipient females

1 reference

https://api.crossref.org/works/10.1002%2FMRD.1123

21 January 2018

Identifiers

10.1002/MRD.1123

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43825956&oldid=2103687126"